These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 30701951)

  • 1. Inhibition of HIF-prolyl 4-hydroxylases as a promising approach to the therapy of cardiometabolic diseases.
    Aitbaev KA; Murkamilov IТ; Fomin VV
    Ter Arkh; 2018 Aug; 90(8):86-94. PubMed ID: 30701951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-inducible factor prolyl 4-hydroxylase inhibition in cardiometabolic diseases.
    Koivunen P; Serpi R; Dimova EY
    Pharmacol Res; 2016 Dec; 114():265-273. PubMed ID: 27832958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-Inducible Factor Prolyl 4-Hydroxylases and Metabolism.
    Koivunen P; Kietzmann T
    Trends Mol Med; 2018 Dec; 24(12):1021-1035. PubMed ID: 30391126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Inhibition Protects Against Development of Atherosclerosis.
    Rahtu-Korpela L; Määttä J; Dimova EY; Hörkkö S; Gylling H; Walkinshaw G; Hakkola J; Kivirikko KI; Myllyharju J; Serpi R; Koivunen P
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):608-17. PubMed ID: 26848160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Knockdown and Pharmacologic Inhibition of Hypoxia-Inducible Factor (HIF) Hydroxylases.
    Pickel C; Taylor CT; Scholz CC
    Methods Mol Biol; 2018; 1742():1-14. PubMed ID: 29330785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIF prolyl 4-hydroxylase-2 inhibition improves glucose and lipid metabolism and protects against obesity and metabolic dysfunction.
    Rahtu-Korpela L; Karsikas S; Hörkkö S; Blanco Sequeiros R; Lammentausta E; Mäkelä KA; Herzig KH; Walkinshaw G; Kivirikko KI; Myllyharju J; Serpi R; Koivunen P
    Diabetes; 2014 Oct; 63(10):3324-33. PubMed ID: 24789921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of HIF-P4H isoenzyme inhibition to metabolism indicates major beneficial effects being conveyed by HIF-P4H-2 antagonism.
    Tapio J; Halmetoja R; Dimova EY; Mäki JM; Laitala A; Walkinshaw G; Myllyharju J; Serpi R; Koivunen P
    J Biol Chem; 2022 Aug; 298(8):102222. PubMed ID: 35787374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIF-prolyl hydroxylases and cardiovascular diseases.
    Sen Banerjee S; Thirunavukkarasu M; Tipu Rishi M; Sanchez JA; Maulik N; Maulik G
    Toxicol Mech Methods; 2012 Jun; 22(5):347-58. PubMed ID: 22424133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic long-term inactivation of hypoxia-inducible factor prolyl 4-hydroxylase 2 ameliorates aging-induced changes in mice without affecting their life span.
    Laitakari A; Huttunen R; Kuvaja P; Hannuksela P; Szabo Z; Heikkilä M; Kerkelä R; Myllyharju J; Dimova EY; Serpi R; Koivunen P
    FASEB J; 2020 Apr; 34(4):5590-5609. PubMed ID: 32100354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-inducible factor prolyl 4-hydroxylases: common and specific roles.
    Myllyharju J; Koivunen P
    Biol Chem; 2013 Apr; 394(4):435-48. PubMed ID: 23324380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The oral hypoxia-inducible factor prolyl hydroxylase inhibitor enarodustat counteracts alterations in renal energy metabolism in the early stages of diabetic kidney disease.
    Hasegawa S; Tanaka T; Saito T; Fukui K; Wakashima T; Susaki EA; Ueda HR; Nangaku M
    Kidney Int; 2020 May; 97(5):934-950. PubMed ID: 32171449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipophilic modification enhances anti-colitic properties of rosmarinic acid by potentiating its HIF-prolyl hydroxylases inhibitory activity.
    Jeong S; Park H; Hong S; Yum S; Kim W; Jung Y
    Eur J Pharmacol; 2015 Jan; 747():114-22. PubMed ID: 25483211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolyl 4-hydroxylases, key enzymes in the synthesis of collagens and regulation of the response to hypoxia, and their roles as treatment targets.
    Myllyharju J
    Ann Med; 2008; 40(6):402-17. PubMed ID: 19160570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The stabilization of hypoxia inducible factor modulates differentiation status and inhibits the proliferation of mouse embryonic stem cells.
    Binó L; Kučera J; Štefková K; Švihálková Šindlerová L; Lánová M; Kudová J; Kubala L; Pacherník J
    Chem Biol Interact; 2016 Jan; 244():204-14. PubMed ID: 26723917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of hypoxia-inducible factor prolyl hydroxylase domain oxygen sensors: tricking the body into mounting orchestrated survival and repair responses.
    Rabinowitz MH
    J Med Chem; 2013 Dec; 56(23):9369-402. PubMed ID: 23977883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and Preclinical Characterization of GSK1278863 (Daprodustat), a Small Molecule Hypoxia Inducible Factor-Prolyl Hydroxylase Inhibitor for Anemia.
    Ariazi JL; Duffy KJ; Adams DF; Fitch DM; Luo L; Pappalardi M; Biju M; DiFilippo EH; Shaw T; Wiggall K; Erickson-Miller C
    J Pharmacol Exp Ther; 2017 Dec; 363(3):336-347. PubMed ID: 28928122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A small-molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase improves obesity, nephropathy and cardiomyopathy in obese ZSF1 rats.
    Signore PE; Guo G; Wei Z; Zhang W; Lin A; Del Balzo U
    PLoS One; 2021; 16(8):e0255022. PubMed ID: 34339435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of in-vitro screening methods on hypoxia inducible factor prolyl hydroxylase inhibitors.
    Wu Y; Jiang Z; You Q; Zhang X
    Bioorg Med Chem; 2017 Aug; 25(15):3891-3899. PubMed ID: 28625716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-N-oxalyl-L-α, β- diaminopropionic acid induces HRE expression by inhibiting HIF-prolyl hydroxylase-2 in normoxic conditions.
    Eslavath RK; Sharma D; Bin Omar NAM; Chikati R; Teli MK; Rajanikant GK; Singh SS
    Eur J Pharmacol; 2016 Nov; 791():405-411. PubMed ID: 27393459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Things get broken: the hypoxia-inducible factor prolyl hydroxylases in ischemic heart disease.
    Schreiber T; Salhöfer L; Quinting T; Fandrey J
    Basic Res Cardiol; 2019 Mar; 114(3):16. PubMed ID: 30859331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.